Literature DB >> 8640021

Long-term survival of 5 years following initial surgery for gastric cancer and simultaneous disseminated peritoneal metastasis: report of a case.

S Otani1, M Maeta, A Oka, Y Hirooka, S Tsujitani, M Ikeguchi, R Hamazoe, N Kaibara.   

Abstract

We report herein the rare case of a patient who survived for 5 years and 10 months after commencing treatment for gastric cancer with simultaneous disseminated peritoneal metastasis. A 45-year-old man was diagnosed as having advanced gastric cancer following the discovery of numerous nodules in the peritoneal cavity at laparotomy. The patient was treated by palliative gastrectomy and continuous hyperthermic peritoneal perfusion (CHPP) immediately after surgery on November 11, 1987. Postoperatively, he underwent radiofrequency (RF) hyperthermia with intraperitoneal cisplatin a total of seven times. He continued on a combination of uracil and tegafur (UFT) administered orally with a protein-bound beta-D-glucan extracted from the mycelia of Cariolus versicolor (PSK). Long-term survival was achieved following the initial palliative gastrectomy despite simultaneous disseminated peritoneal metastasis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8640021     DOI: 10.1007/bf00312381

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  8 in total

1.  Does the extent of lymph node dissection affect the postoperative survival of patients with gastric cancer and disseminating peritoneal metastasis?

Authors:  M Maeta; A Sugesawa; M Ikeguchi; S Tsujitani; H Yamashiro; S Shibata; A Kondo; N Kaibara
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

2.  Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C.

Authors:  S Koga; R Hamazoe; M Maeta; N Shimizu; A Murakami; T Wakatsuki
Journal:  Cancer       Date:  1988-01-15       Impact factor: 6.860

3.  Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study.

Authors:  R Hamazoe; M Maeta; N Kaibara
Journal:  Cancer       Date:  1994-04-15       Impact factor: 6.860

4.  The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification.

Authors:  T Kajitani
Journal:  Jpn J Surg       Date:  1981-03

5.  Heating efficiency of radiofrequency capacitive hyperthermia for treatment of deep-seated tumors in the peritoneal cavity.

Authors:  R Hamazoe; M Maeta; A Murakami; H Yamashiro; N Kaibara
Journal:  J Surg Oncol       Date:  1991-11       Impact factor: 3.454

6.  Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Study Group of Immunochemotherapy with PSK for Gastric Cancer.

Authors:  H Nakazato; A Koike; S Saji; N Ogawa; J Sakamoto
Journal:  Lancet       Date:  1994-05-07       Impact factor: 79.321

7.  Multi-institutional studies on hyperthermia using an 8-MHz radiofrequency capacitive heating device (Thermotron RF-8) in combination with radiation for cancer therapy.

Authors:  M Abe; M Hiraoka; M Takahashi; S Egawa; C Matsuda; Y Onoyama; K Morita; M Kakehi; T Sugahara
Journal:  Cancer       Date:  1986-10-15       Impact factor: 6.860

8.  Early postoperative chemotherapy following noncurative resection for patients with advanced gastric cancer.

Authors:  Y Maehara; K Sugimachi; M Akagi; T Kakegawa; H Shimazu; M Tomita
Journal:  Br J Cancer       Date:  1992-03       Impact factor: 7.640

  8 in total
  4 in total

1.  Relationship between expression of apoptosis-related proteins and the efficacy of postoperative chemotherapy in patients with T3 gastric cancer.

Authors:  Shunichi Tsujitani; Hiroaki Saito; Toshiro Wakatsuki; Masahide Ikeguchi; Ken Shirabe; Masaru Morita; Yoshihiro Kakeji; Tokujiro Yano; Yoshihiko Maehara
Journal:  Surg Today       Date:  2011-12-06       Impact factor: 2.549

2.  Expression of p53 and p21 are independent prognostic factors in patients with serosal invasion by gastric carcinoma.

Authors:  M Ikeguchi; H Saito; K Katano; S Tsujitani; M Maeta; N Kaibara
Journal:  Dig Dis Sci       Date:  1998-05       Impact factor: 3.199

3.  Clinicopathologic characteristics of gastric cancer patients who underwent noncurative gastrectomy with long-term survival.

Authors:  Hiroaki Saito; Yoshinori Yamada; Shunichi Tsujitani; Masahide Ikeguchi
Journal:  Langenbecks Arch Surg       Date:  2008-08-02       Impact factor: 3.445

4.  Palliative gastrectomy and chemotherapy for stage IV gastric cancer.

Authors:  Sheng-Zhang Lin; Hong-Fei Tong; Tao You; Yao-Jun Yu; Wei-Jun Wu; Cong Chen; Wei Zhang; Bing Ye; Chun-Ming Li; Zhi-Qiang Zhen; Jia-Rong Xu; Jun-Liang Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-05       Impact factor: 4.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.